Business Standard

Titan Biotech consolidated net profit declines 37.67% in the December 2022 quarter

Image

Capital Market

Sales decline 16.74% to Rs 30.33 crore

Net profit of Titan Biotech declined 37.67% to Rs 3.26 crore in the quarter ended December 2022 as against Rs 5.23 crore during the previous quarter ended December 2021. Sales declined 16.74% to Rs 30.33 crore in the quarter ended December 2022 as against Rs 36.43 crore during the previous quarter ended December 2021. ParticularsQuarter EndedDec. 2022Dec. 2021% Var.Sales30.3336.43 -17 OPM %13.6523.85 -PBDT4.288.58 -50 PBT3.637.96 -54 NP3.265.23 -38

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Feb 04 2023 | 4:34 PM IST

Explore News